The intracerebroventricular administration of high-affinity PPARβ/δ agonists significantly decreases the infarct volume at 24 h of reperfusion after cerebral ischemia in rats, again underscoring the anti-inflammatory and neuroprotective properties of PPARβ/δ [652]. This evidence concerns the gene PPARD and brain ischemia.